Evidence map›Paper›PMID 22318450›Full record

ArticleLeukemia2012

Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.

M Schoenhals, C Frecha, A Bruyer, A Caraux, J L Veyrune, M Jourdan, J Moreaux, F-L Cosset, E Verhoeyen, B Klein

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Leukemia, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

M SchoenhalsINSERM U1040, Institute for Research in Biotherapy, CHU Montpellier, Hospital St Eloi, Montpellier, France.
C Frecha
A Bruyer
A Caraux
J L Veyrune
M Jourdan
J Moreaux
F-L Cosset
E Verhoeyen
B Klein
Inserm · FRCentre Hospitalier Universitaire de Montpellier · FRÉcole Normale Supérieure de Lyon · FRInstitute for Regenerative Medicine & Biotherapy · FRVirologie et Pathologies Humaines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A lot of genes deregulated in malignant plasma cells (PCs) involved in multiple myeloma have been reported these last years. The expression of some of these genes is associated with poor survival. A critical step is to elucidate the biological mechanisms triggered by these gene products. Such studies are hampered by the difficulty to obtain malignant PCs and to genetically modify them. Usual lentiviral vectors (LVs) pseudotyped with vesicular stomatitis virus envelope glycoprotein poorly transduced healthy and malignant PCs. Here, we report that LVs pseudotyped with the hemagglutinin and fusion glycoproteins from the measles Edmonston strain (H/F-LVs) can efficiently and stably transduce healthy and primary malignant PCs, without modifying their main phenotypic characteristics. Both LV pseudotypes efficiently transduced human myeloma cell lines. Importantly, both healthy and malignant PCs expressed CD46 and SLAMF1/CD150 membrane proteins, which are critical receptors for binding and productive genetic modification by H/F-LVs. The ability to efficiently introduce and express a given gene into PCs opens the possibility to study in detail PC biology.

Indexed as

Genetic VectorsAntigens, CDCells, CulturedFlow CytometryFluorescent Antibody TechniqueGenetic TherapyGene Transfer TechniquesGlycoproteinsHumansImmunophenotypingLentivirusMeasles virusMembrane Cofactor ProteinMultiple MyelomaPlasma CellsReceptors, Cell SurfaceAntigens, CDGlycoproteinsMembrane Cofactor ProteinReceptors, Cell SurfaceSignaling Lymphocytic Activation Molecule Family Member 1SLAMF1 protein, humanViral Envelope Proteins

Identifiers

PMID22318450
OpenAlexW2010755656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.